KA081020-065

General Information


DRACP ID  DRACP02003

Peptide Name   KA081020-065

Sequence  MRGENMSEGNRPEGTPHGLRSTPARELPIPAFLEPAR

Sequence Length  37

UniProt ID  I3TKW5 

PubChem CID  Not available

Origin  Tistrella mobilis (strain KA081020-065)

Type  Native peptide

Classification

  

Not available



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma Not available Not available Not available 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02003

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C173H280N56O54S2

Absent amino acids  CDKQVWY

Common amino acids  P

Mass  471486

Pl  7.56

Basic residues  6

Acidic residues  5

Hydrophobic residues  8

Net charge  1

Boman Index  -10198

Hydrophobicity  -98.65

Aliphatic Index  50.27

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22458477

Title  Bacterial biosynthesis and maturation of the didemnin anti-cancer agents

Doi 10.1021/ja301735a

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.